RADIANT and SELECT: Is Adjuvant Erlotinib Effective in Early-Stage Lung Cancer? episode artwork

EPISODE · Aug 5, 2014 · 16 MIN

RADIANT and SELECT: Is Adjuvant Erlotinib Effective in Early-Stage Lung Cancer?

from GRACEcast · host cancerGRACE Meetings

Drs. Nasser Hanna and Melissa Johnson discuss new trial evidence for the use of adjuvant Eroltinib for early-stage lung cancer.

Episode metadata supplied by the publisher feed · Published Aug 5, 2014

Embed this episode

NOW PLAYING

RADIANT and SELECT: Is Adjuvant Erlotinib Effective in Early-Stage Lung Cancer?

0:00 16:43

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

Frequently Asked Questions

How long is this episode of GRACEcast?

This episode is 16 minutes long.

When was this GRACEcast episode published?

This episode was published on August 5, 2014.

Can I download this GRACEcast episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!